Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors
- 1 August 2002
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 123 (2) , 608-618
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low‐endemic areaLiver International, 2000
- Results after nonsurgical local treatment of primary liver malignanciesLangenbeck's Archives of Surgery, 2000
- Metastasectomy as a cytoreductive strategy for treatment of isolated pulmonary and hepatic metastases from breast cancerSurgical Oncology, 1999
- Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgeryAnnals of Oncology, 1999
- Treatment of colorectal liver metastasesBritish Journal of Surgery, 1999
- Results of surgical resection of liver metastases from non-colorectal primariesBritish Journal of Surgery, 1998
- p53 in Tumor Progression: Life, Death, and Everything1998
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- Resection of Nonresectable Liver Metastases from Colorectal Cancer After Neoadjuvant ChemotherapyAnnals of Surgery, 1996
- p53 Mutations in Human CancersScience, 1991